A Guide for Selection of Genetic Instruments in Mendelian Randomization Studies of Type 2 Diabetes and HbA1c: Toward an Integrated Approach.

"Research Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. NC receives funds for serving on clinical trial data safety and monitoring committees sponsored by AstraZeneca. The remaining authors declare that there are no conflicts of interest. VG is the guarantor of this manuscript and takes full responsibility for the work, including the study design, access to data, and the decision to submit and publish the manuscript. We acknowledge Dr Chloe Park (MRC LHA, UCL) for her help with creating the graphical overview."

"This work was conducted under the approved UK Biobank project number 7661. We thank the volunteer participants of the UK Biobank, and the UK Biobank researchers. VG is jointly funded by Diabetes UK (15/0005250) and British Heart Foundation grant (SP/16/6/32726). AS and NC are supported by the UK Medical Research Council (MC_ST_LHA_2019, MC_UU_0019/2). SB is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204623/Z/16/Z). This research was supported by the National Institute for Health"